Clinical Trial Update: A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure [Phase 2]

View source ↗

Summary

The document reports a Phase IIb trial of AZD5462 in chronic heart failure has completed; no results are provided in the excerpt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• AZD5462

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Heart Failure | Phase 2 | Status: COMPLETED